EDG-5506

EDG-5506 · Edgewise Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for EDG-5506, covering 2025-06-24 to 2026-03-24. Get the full timeline:

Most recent: Clinical Trial Update: Open-Label Extension of EDG-5506 in Participants With Becker Muscular Dystrophy [Phase 2]